ArticleCancer immunology, immunotherapy : CII2021

A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186.

Cameron J Herting et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.